Prostate cancer in Asia: A collaborative report. Chen, R., Ren, S., Yiu, M. K., Fai, N. C., Cheng, W. S., Ian, L. H., Naito, S., Matsuda, T., Kehinde, E., Kural, A., Chiu, J. Y., Umbas, R., Wei, Q., Shi, X., Zhou, L., Huang, J., Huang, Y., Xie, L., Ma, L., Yin, C., Xu, D., Xu, K., Ye, Z., Liu, C., Ye, D., Fu, Q., Hou, J., Yuan, J., He, D., Pan, T., Ding, Q., Jin, F., Shi, B., Wang, G., Liu, X., Wang, D., Shen, Z., Kong, X., Xu, W., Deng, Y., Xia, H., Cohen, A. N., Gao, X., Xu, C., & Sun, Y. Asian Journal of Urology, 1(1):15–29, 2014.
Prostate cancer in Asia: A collaborative report [link]Paper  doi  abstract   bibtex   
The incidence of prostate cancer (PCA) within Asian population used to be much lower than in the Western population; however, in recent years the incidence and mortality rate of PCA in some Asian countries have grown rapidly. This collaborative report summarized the latest epidemiology information, risk factors, and racial differences in PCA diagnosis, current status and new trends in surgery management and novel agents for castration-resistant prostate cancer. We believe such information would be helpful in clinical decision making for urologists and oncologists, health-care ministries and medical researchers.Copyright © 2014 Editorial Office of Asian Journal of Urology.
@article{chen_prostate_2014,
	title = {Prostate cancer in {Asia}: {A} collaborative report},
	volume = {1},
	issn = {2214-3890 (electronic) 2214-3890},
	url = {http://www.journals.elsevier.com/asian-journal-of-urology/ http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=emed15&NEWS=N&AN=610048600},
	doi = {10.1016/j.ajur.2014.08.007},
	abstract = {The incidence of prostate cancer (PCA) within Asian population used to be much lower than in the Western population; however, in recent years the incidence and mortality rate of PCA in some Asian countries have grown rapidly. This collaborative report summarized the latest epidemiology information, risk factors, and racial differences in PCA diagnosis, current status and new trends in surgery management and novel agents for castration-resistant prostate cancer. We believe such information would be helpful in clinical decision making for urologists and oncologists, health-care ministries and medical researchers.Copyright © 2014 Editorial Office of Asian Journal of Urology.},
	language = {English},
	number = {1},
	journal = {Asian Journal of Urology},
	author = {Chen, R. and Ren, S. and Yiu, M. K. and Fai, N. C. and Cheng, W. S. and Ian, L. H. and Naito, S. and Matsuda, T. and Kehinde, E. and Kural, A. and Chiu, J. Y. and Umbas, R. and Wei, Q. and Shi, X. and Zhou, L. and Huang, J. and Huang, Y. and Xie, L. and Ma, L. and Yin, C. and Xu, D. and Xu, K. and Ye, Z. and Liu, C. and Ye, D. and Fu, Q. and Hou, J. and Yuan, J. and He, D. and Pan, T. and Ding, Q. and Jin, F. and Shi, B. and Wang, G. and Liu, X. and Wang, D. and Shen, Z. and Kong, X. and Xu, W. and Deng, Y. and Xia, H. and Cohen, A. N. and Gao, X. and Xu, C. and Sun, Y.},
	year = {2014},
	keywords = {*Asia, *prostate cancer, China, Hong Kong, India, Indonesia, Japan, Korea, Malaysia, Philippines, Singapore, Taiwan, Thailand, Turkey (republic), abiraterone, age, article, cabazitaxel, cancer grading, cancer incidence, cancer mortality, cancer risk, cancer screening, cancer staging, cause of death, diet, economic development, environmental factor, enzalutamide, genetic association, genetic difference, genetic variability, human, lifestyle modification, overall survival, prostate biopsy, prostate specific antigen/ec [Endogenous Compound], prostatectomy, risk factor, sipuleucel T, survival time},
	pages = {15--29},
}

Downloads: 0